Skip to main content
. 2019 Dec 3;12:2549–2557. doi: 10.2147/DMSO.S190356

Table 1.

Pharmacokinetic Parameters of Approved SGLT-2 Inhibitors12,13

SGLT-2 Inhibitor Bioavailability Time to Peak Action (Hours) Half-Life (Hours) SGLT-2 Inhibitor Selectivity Over SGLT-1
Canagliflozin ~ 65% 1–2 h 11–13 h 1:414
Dapagliflozin ~ 78% 1–1.5 h 13 h 1:1200
Empagliflozin ~75% 1.5 h 13 h 1:2500
Ertugliflozin 70–90% 0.5–1.5 h 11–17 h 1:2000

Abbreviation: SGLT-2, sodium-glucose co-transporter 2.